Position in PFE
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$41,784,049
-$14,140,472 QoQ
Shares Held
1,735,218
-12.9% QoQ
Ownership
0.030%
of shares outstanding
% of Portfolio
0.70%
of 13F equity value
Holder Rank
#199
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CRAWFORD INVESTMENT COUNSEL INC holds $569,205,568 across 10 Drug Manufacturers - General names. PFE ranks #4 (7.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
818,972 | $206,086,114 | |
| 2 | AZN |
Astrazeneca PLC
|
708,224 | $134,293,434 | |
| 3 | JNJ |
Johnson & Johnson
|
468,190 | $118,906,214 | |
| 4 | PFE |
Pfizer Inc
This page
|
1,735,218 | $41,784,049 | |
| 5 | GSK |
GSK plc
|
634,985 | $33,285,913 | |
| 6 | MRK |
Merck & Co., Inc.
|
144,979 | $18,629,801 | |
| 7 | LLY |
ELI LILLY & Co
|
8,977 | $10,767,284 | |
| 8 | AMGN |
Amgen Inc
|
7,793 | $2,822,001 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $41,784,049 | 1,735,218 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $55,924,521 | 1,991,614 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $51,857,511 | 2,082,631 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $54,915,642 | 2,155,245 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $51,929,642 | 2,142,312 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $55,164,115 | 2,176,958 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $52,715,773 | 1,987,025 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $53,405,065 | 1,845,372 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $50,865,513 | 1,817,924 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $49,321,157 | 1,777,339 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $44,697,540 | 1,552,537 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $47,193,181 | 1,422,767 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $51,100,155 | 1,393,134 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $50,376,453 | 1,234,717 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $31,859,392 | 621,768 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $27,678,593 | 632,509 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $32,234,698 | 614,814 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $31,542,839 | 609,288 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $38,263,159 | 647,979 | Shares | Sole | 2022-02-07 | |
| 2021-09-30 | $29,183,360 | 678,525 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $28,423,189 | 725,822 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $25,365,021 | 700,111 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $23,960,990 | 650,937 | Shares | Sole | 2021-02-01 | |
| 2020-09-30 | $21,644,611 | 589,772 | Shares | Sole | 2020-10-29 | |
| 2020-06-30 | $17,137,237 | 524,074 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $14,685,695 | 449,930 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||